[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL43589A - 16-phenoxy-15-hydroxy derivatives of 17,18,19,20-tetranorprostaglandins and their preparation - Google Patents

16-phenoxy-15-hydroxy derivatives of 17,18,19,20-tetranorprostaglandins and their preparation

Info

Publication number
IL43589A
IL43589A IL43589A IL4358973A IL43589A IL 43589 A IL43589 A IL 43589A IL 43589 A IL43589 A IL 43589A IL 4358973 A IL4358973 A IL 4358973A IL 43589 A IL43589 A IL 43589A
Authority
IL
Israel
Prior art keywords
compound
double bond
phenoxy
phenyl
cis
Prior art date
Application number
IL43589A
Other languages
English (en)
Other versions
IL43589A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IL50307A priority Critical patent/IL50307A/xx
Publication of IL43589A0 publication Critical patent/IL43589A0/xx
Publication of IL43589A publication Critical patent/IL43589A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL43589A 1972-11-08 1973-11-07 16-phenoxy-15-hydroxy derivatives of 17,18,19,20-tetranorprostaglandins and their preparation IL43589A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL50307A IL50307A (en) 1972-11-08 1973-11-07 Dimethyl 2-oxo-3-phenoxypropyl phosphonates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481372A 1972-11-08 1972-11-08

Publications (2)

Publication Number Publication Date
IL43589A0 IL43589A0 (en) 1974-03-14
IL43589A true IL43589A (en) 1980-01-31

Family

ID=23178133

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43589A IL43589A (en) 1972-11-08 1973-11-07 16-phenoxy-15-hydroxy derivatives of 17,18,19,20-tetranorprostaglandins and their preparation

Country Status (29)

Country Link
JP (3) JPS5416491B2 (xx)
AR (3) AR200585A1 (xx)
AT (3) AT367034B (xx)
AU (1) AU470375B2 (xx)
BE (1) BE806995A (xx)
CA (3) CA1085831A (xx)
CH (1) CH597176A5 (xx)
CS (3) CS182793B2 (xx)
DD (4) DD118856A5 (xx)
DE (1) DE2355540C2 (xx)
DK (1) DK144247C (xx)
ES (3) ES420325A1 (xx)
FI (1) FI60389C (xx)
FR (3) FR2205335B1 (xx)
GB (3) GB1456513A (xx)
HK (3) HK28179A (xx)
HU (3) HU171819B (xx)
IE (1) IE39537B1 (xx)
IL (1) IL43589A (xx)
IN (1) IN139384B (xx)
KE (3) KE2930A (xx)
MY (3) MY7900243A (xx)
NL (1) NL164273C (xx)
NO (3) NO147836C (xx)
PH (3) PH13272A (xx)
SE (4) SE448992B (xx)
SU (4) SU584766A3 (xx)
YU (3) YU39715B (xx)
ZA (1) ZA738554B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3986764A (en) * 1975-03-31 1976-10-19 Gte Automatic Electric Laboratories Incorporated Panel for supporting a pair of elongated mating connectors and selectively locking them together
GB1506816A (en) * 1975-03-31 1978-04-12 Upjohn Co Prostaglandins
ES449162A1 (es) * 1975-06-23 1977-12-16 Syntex Inc Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
GB1516414A (en) * 1975-08-22 1978-07-05 Ici Ltd Prostane derivatives
SE7809008L (sv) * 1977-12-12 1979-06-13 Upjohn Co Anvendning av amider av prostaglandintyp for att styra eller reglera reproduktionscykeln hos individer tillhorande deggdjursarter
IN150279B (xx) * 1978-01-16 1982-09-04 Pfizer
WO1999012898A1 (en) * 1997-09-09 1999-03-18 The Procter & Gamble Company Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
HUP0200258A2 (hu) 1999-03-05 2002-05-29 The Procter & Gamble Co. C16-telítetlen FP-szelektív prosztaglandin analógok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
JP2002329615A (ja) * 2001-05-02 2002-11-15 Ohira Denshi Kk トロイダルコイル
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
EP1812017A2 (en) 2004-10-21 2007-08-01 Duke University Ophthamological drugs
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives

Also Published As

Publication number Publication date
SE7700717L (sv) 1977-01-24
SE445111B (sv) 1986-06-02
SU893130A3 (ru) 1981-12-23
FI60389B (fi) 1981-09-30
AR200585A1 (es) 1974-11-22
CS182794B2 (en) 1978-05-31
PH13325A (en) 1980-03-13
KE2930A (en) 1979-03-30
YU37316B (en) 1984-08-31
NO149139B (no) 1983-11-14
YU288073A (en) 1982-02-28
YU270680A (en) 1983-04-27
AU6224773A (en) 1975-05-08
IN139384B (xx) 1976-06-12
GB1456513A (en) 1976-11-24
DD117233A5 (xx) 1976-01-05
AR199966A1 (es) 1974-10-08
FR2283146B1 (xx) 1981-06-19
HU173507B (hu) 1979-05-28
GB1456514A (en) 1976-11-24
FR2279729B1 (xx) 1978-04-28
DK144247B (da) 1982-01-25
DE2355540C2 (de) 1982-11-18
YU36975B (en) 1984-08-31
CS182793B2 (en) 1978-05-31
SE7700716L (sv) 1977-01-24
DE2365322A1 (de) 1974-11-07
AT353285B (de) 1979-11-12
NL164273C (nl) 1980-12-15
DD119411A5 (xx) 1976-04-20
NO149139C (no) 1984-02-29
NO148998B (no) 1983-10-17
KE2931A (en) 1979-03-30
PH13110A (en) 1979-11-28
SE7700718L (sv) 1977-01-24
AT360672B (de) 1981-01-26
ES420325A1 (es) 1976-04-16
FR2283146A1 (fr) 1976-03-26
FR2205335A1 (xx) 1974-05-31
ES433047A1 (es) 1976-11-01
ATA936973A (de) 1981-10-15
AU470375B2 (en) 1976-03-11
SE431756B (sv) 1984-02-27
FR2205335B1 (xx) 1978-07-13
NO147836B (no) 1983-03-14
JPS5416491B2 (xx) 1979-06-22
SE436278B (sv) 1984-11-26
HK28179A (en) 1979-05-11
MY7900246A (en) 1979-12-31
CA1088930A (en) 1980-11-04
PH13272A (en) 1980-02-27
HU171819B (hu) 1978-03-28
JPS4993342A (xx) 1974-09-05
DD109212A5 (xx) 1974-10-20
SU745362A3 (ru) 1980-06-30
BE806995A (fr) 1974-05-07
AT367034B (de) 1982-05-25
HK28079A (en) 1979-05-11
DD118856A5 (xx) 1976-03-20
IL43589A0 (en) 1974-03-14
CA1088931A (en) 1980-11-04
CH597176A5 (xx) 1978-03-31
ATA544676A (de) 1979-04-15
KE2932A (en) 1979-03-30
MY7900245A (en) 1979-12-31
CS182791B2 (en) 1978-05-31
JPS5257147A (en) 1977-05-11
ZA738554B (en) 1974-09-25
IE39537L (en) 1974-05-08
CA1085831A (en) 1980-09-16
HK27979A (en) 1979-05-11
ES433046A1 (es) 1977-06-16
NO743493L (no) 1974-05-09
NO147836C (no) 1983-06-22
IE39537B1 (en) 1978-11-08
GB1456512A (en) 1976-11-24
NO750535L (xx) 1974-05-09
ATA544576A (de) 1980-06-15
DE2365322B2 (de) 1977-02-24
MY7900243A (en) 1979-12-31
NO148998C (no) 1984-01-25
SU584766A3 (ru) 1977-12-15
FR2279729A1 (fr) 1976-02-20
AR202931A1 (es) 1975-07-31
NL7315263A (xx) 1974-05-10
DE2355540A1 (de) 1974-05-22
DK144247C (da) 1982-07-12
HU172703B (hu) 1978-11-28
YU270780A (en) 1982-06-18
JPS5253841A (en) 1977-04-30
FI60389C (fi) 1982-01-11
YU39715B (en) 1985-04-30
SE448992B (sv) 1987-03-30
SU667141A3 (ru) 1979-06-05

Similar Documents

Publication Publication Date Title
US4087604A (en) Substituted ω-pentanorprostaglandins
US4304907A (en) Bicyclo lactone intermediates for prostaglandin analogs
IL43589A (en) 16-phenoxy-15-hydroxy derivatives of 17,18,19,20-tetranorprostaglandins and their preparation
US4073934A (en) Novel acetylenic prostaglandin analogs
DE2659215A1 (de) Prostaglandin-analoga
EP0299914A1 (de) 9-Halogen-(Z)-prostaglandinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US4011262A (en) 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
CH628028A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14.
US4699920A (en) 9-halo-2-prostaglandin derivatives, processes for the preparation thereof and use thereof as medicinal agents
US4033989A (en) 9-Deoxy-PGF2 Analogs
US4013695A (en) 4,4,5,5-Tetradehydro-PGE1 analogs
US4169895A (en) Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4060534A (en) 9-Deoxy-9-methylene-PGF compounds
IE44016B1 (en) 11-deoxy-16-aryl-17,18,19,20-tetranorprostaglandins
CA1092102A (en) 11-oxo-prostaglandin derivatives and processes for their manufacture
IE47549B1 (en) Acetyleneprostaglandins and process for their production
US4035415A (en) Omega-nor-cycloalkyl-13,14-dehydro-prostaglandins
CH642063A5 (de) Verfahren zur herstellung von prostaglandin-analoga, bei welchen die carbonylgruppe am c-9 durch eine methylengruppe ersetzt ist.
US4229585A (en) Fluoro-prostaglandins
US4404372A (en) 15-Substituted-ω-pentanorprostaglandin derivatives
DE2606051A1 (de) 2,2-difluor-prostaglandin-e, -f tief alpha, -f tief beta, -a und -b-analoga und verfahren zu deren herstellung
JPS6126970B2 (xx)
US4078021A (en) Dimethyl 2-oxo-6-cyanohexyl-phosphonate
JPS6049632B2 (ja) 16−フェノキシ プロスタ グランジン類似体
US4244887A (en) Substituted ω-pentanorprostaglandins